Search Results - "ZABOTINA, T. N"

Role of P-glycoprotein in evolution of populations of chronic myeloid leukemia cells treated with imatinib by Stromskaya, T. P, Rybalkina, E. Yu, Kruglov, S. S, Zabotina, T. N, Mechetner, E. B, Turkina, A. G, Stavrovskaya, A. A

“…Imatinib mesylate (imatinib) is a new generation preparation that is now successfully used for treatment of cancer, particularly for chemotherapy of chronic…”
Get full text

Analysis of the lymphoid tumor microenvironment (TILs) in breast cancer by flow cytometry by Zabotina, T. N., Borunova, A. A., Сhertkova, A. I., Shoua, I. B., Kadagidze, Z. G.

“…Despite the success in early diagnosis and drug treatment of breast cancer patients, long-term treatment results are still unsatisfactory, and in this regard,…”
Get full text

Tumor-Infiltrating Lymphocytes in Breast Cancer. Association with Clinical and Pathological Parameters by Zabotina, T. N., Korotkova, O. V., Chertkova, A. I., Zakharova, E. N., Tabakov, D. V., Dzhgamadze, N. T., Savostikova, M. V., Artamonova, E. V., Khailenko, V. A., Kovalenko, E. I., Kadagidze, Z. G.

“…In patients with primary resectable breast cancer, a positive correlation between the age and the count of CD16 + lymphocytes and a negative correlation of…”
Get full text

ASSOCIATION OF NKT- AND ACTIVATED CD25+ PERIPHERAL BLOOD LYMPHOCYTES WITH DISEASE FREE AND OVERALL SURVIVAL OF TRIPLE NEGATIVE BREAST CANCER PATIENTS by Chertkova, A. I., Slavina, E. G., Zabotina, T. N., Kadagidze, Z. G., Shoua, E. K., Gordeeva, O. O., Kolyadina, I. V., Zhukova, L. G., Gan’shina, I. P., Meshcheryakov, A. A.

“…Background . We previously found that a decrease in the number of NKT cells and activated CD 25+ peripheral blood lymphocytes (PBLs) before neoadjuvant…”
Get full text

Analysis of systemic immunity and inflammation in the prognosis of gastric adenocarcinoma by Khakimova, G. G., Zabotina, T. N., Tryakin, A. A., Borunova, A. A., Davidova, T. V., Kalinin, A. E., Vakhabova, Yu. V., Zakharova, E. N., Tabakov, D. V.

“…Objective: to study the state of cellular immunity in patients with gastric adenocarcinoma. Materials and methods. From 2017 to 2018, 45 previously untreated…”
Get full text

Intracellular localization and content of YB-1 protein in multidrug resistant tumor cells by Vaiman, A V, Stromskaya, T P, Rybalkina, E Yu, Sorokin, A V, Guryanov, S G, Zabotina, T N, Mechetner, E B, Ovchinnikov, L P, Stavrovskaya, A A

“…The multifunctional mammalian protein YB-1 is a member of the large DNA- and RNA-binding protein family with an evolutionarily ancient cold-shock domain. YB-1…”
Get full text

Anti-cancer activity of сuraxin CBL0137 on the models of acute leukemia in vitro by Fetisov, T. I., Kirsanov, K. I., Borunova, A. A., Zatsepina, M. N., Lesovaya, E. A., Zabotina, T. N., Belitsky, G. A., Yakubovskaya, M. G.

“…Background. Curaxin CBL0137 is a novel non-genotoxic compound with anti-cancer activity based on CBL0137 ability of non-covalent interaction with DNA causing…”
Get full text

Activation of interferon-α signaling by resveratrol, genistein and quercetin by Vlasova, O. A., Borunova, A. A., Safina, A., Smetanina, I. V., Lesovaya, E. A., Belitsky, G. A., Zabotina, T. N., Gurova, K., Kirsanov, K. I., Yakubovskaya, M. G.

“…Resveratrol, genistein and quercetin from the group of polyphenols from secondary plant metabolites reveal cancer preventive and antivirus effects realized via…”
Get full text

The necessity and advantages of personified neck lymph node dissection in T1-2N0M0 oral mucosa cancer. A pathway to radical surgery by Margolin, G., Mudunov, A. М., Gelfand, I. M., Alymov, Yu. V., Akhundov, A. A., Podvyaznikov, S. О., Narimanov, M. N., Zabotina, T. N., Zakharova, E. N.

“…The study objective is to investigate the causes of insufficient efficiency of neck lymph node dissection and possibilities of its improvement in cancer of the…”
Get full text

HETEROGENEITY OF NK AND NKT LYMPHOCYTE POPULATIONS IN HEALTHY DONORS by Tabakov, D V., Zabotina, T. N., Borunova, A. A., Panchuk, I. O., Korotkova, O. V., Kadagidze, Z. G.

“…Natural killer(NK) and  NKT lymphocytes are important components of innate immunity, and compose a first-line defense against cancer. These populations are…”
Get full text

Role of P-glycoprotein in evolution of populations of chronic myeloid leukemia cells treated with imatinib by Stromskaya, T P, Rybalkina, E Yu, Kruglov, S S, Zabotina, T N, Mechetner, E B, Turkina, A G, Stavrovskaya, A A

“…Imatinib mesylate (imatinib) is a new generation preparation that is now successfully used for treatment of cancer, particularly for chemotherapy of chronic…”
Get full text

Influence of exogenous RAR alpha gene on MDR1 expression and P-glycoprotein function in human and rodent cell lines by Stromskaya, T P, Rybalkina, E Y, Shtil, A A, Zabotina, T N, Filippova, N A, Stavrovskaya, A A

“…The goal of our study was to obtain direct evidence of co-ordinated regulation of P-glycoprotein (P-gp)-mediated multidrug resistance (MDR) and differentiation…”
Get full text

CD95 (FAS/APO-1) antigen is a new prognostic marker of blast cells of acute lymphoblastic leukaemia patients by Baryshnikov AYu, Polosukhina, E R, Tupitsin, N N, Gavrikova, N V, Andreeva LYu, Zabotina, T N, Mayakova, S A, Kurmashov, V I, Syrkin, A B, Kadagidze, Z G, Blochin DYu, Shishkin YuV

“…We analyzed CD95(Fas/APO-1) antigen expression on bone marrow blasts in 38 children with acute lymphoblastic leukemia (ALL) receiving a treatment in the…”
Get more information

HETEROGENEITY OF NK AND NKT LYMPHOCYTE POPULATIONS IN HEALTHY DONORS by Tabakov, D V, Zabotina, T N, Borunova, A A, Panchuk, I O, Korotkova, O V, Kadagidze, Z G

“…Natural killer(NK) and NKT lymphocytes are important components of innate immunity, and compose a first-line defense against cancer. These populations are…”
Get full text

New approach to vital analysis of functional activity in ABC transporters (markers for multidrug resistance) in solid tumors by the method of flow cytofluorometry by Bogush, T A, Zabotina, T N, Bogush, E A, Chmutin, E F, Komov, D V, Kadagidze, Z G, Baryshnikov, A Yu

“…We developed and described a new approach to vital analysis of functional activity of multidrug resistance markers (ABC transporters) in intact biopsy…”
Get full text

Comparative Analysis of Cells with Combined Apoptosis and Proliferation Markers in Thyroid Tissue Specimens from Patients with Cancer, Adenoma, and Autoimmune Diseases by Kazakov, S. P., Zabotina, T. N., Korotkova, O. V., Dzabarov, A. K., Kazantseva, I. A.

“…Combined phenotypes of cells with membrane and intracellular expression of apoptosis and proliferation regulation markers (p53, bcl-2, CD95, CD95L, Ki-67) were…”
Get full text

A new marker of tamoxifen resistance of estrogen receptor-positive breast cancer by Bogush, E A, Ravcheeva, A B, Bogush, T A, Zabotina, T N, Kadagidze, Z G, Davydov, M I

“…(ProQuest: Abstract omitted; see image)[PUBLICATION ABSTRACT]…”
Get full text

Variations in the number of regulatory T cells (CD4+CD25+) in patients with breast cancer during herceptin therapy by Slavina, E G, Chertkova, A I, Zabotina, T N, Gan'shina, I P, Lichinitser, M R

“…We studied the effect of Herceptin therapy on the population composition of lymphocytes and percentage of CD4+CD25+ cells (regulatory T cells) in breast cancer…”
Get full text

Isolation and characterization of ICO-160 monoclonal antibodies to CD95(Fas/APO-1) antigen that mediates apoptosis by Polosukhina, E. R., Zabotina, T. N., Shishkin, Yu. V., Kadagidze, Z. G., Baryshnikov, A. Yu

“…Isotype IgG2a monoclonal antibodies ICO-160, detecting CD95(Fas/APO-1) antigen, were isolated and characterized. They react with 26.8±15.6% donor lymphocytes…”
Get full text

Characteristics of drug resistance of tumor plasmocytes in vitro in patients with multiple myeloma differently responsive to chemotherapy by Golenkov, A K, Trifonova, E V, Kataeva, E V, Kil'diushevskiĭ, A V, Lutskaia, T D, Zariad'eva, E A, Nazarova, I N, Lukashina, M N, Zabotina, T N, Mikhaĭlova, I N, Inshakov, A N, Logacheva, N P, Baryshnikov, A Iu

“…To determine sensitivity of tumor plasmocytes in vitro to cytostatic drugs (prednisolone, alkeran belustin, vincristine, rubomycin, doxorubicin, cytarabin,…”
Get more information